Lignocad Adr is a prescription drug, available for use as Injection. Local Anesthesia, Allergy, Heart Failure are some of its major therapeutic uses. Secondary and off-label uses of Lignocad Adr have also been mentioned below.
The optimal dosage of Lignocad Adr is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of Lignocad Adr include Skin redness. While these are the most often observed Lignocad Adr side effects, there are can be others also. These have been listed below. These side effects of Lignocad Adr are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Lignocad Adr's effect is Unknown during pregnancy and Unknown for lactating mothers. It is important to know if Lignocad Adr has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Lignocad Adr related warnings section.
Lignocad Adr is contraindicated in people with pre-existing medical conditions like Heart Failure, Liver Disease, Heart Disease as it can result in adverse effects. Some other conditions that can be affected by Lignocad Adr are listed in the contraindications section below.
Additionally, Lignocad Adr may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Lignocad Adr is safe while driving, and is addiction.
Lignocad Adr is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Lignocad Adr safe for pregnant women?
It is not known what effect Lignocad Adr will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Lignocad Adr safe during breastfeeding?
In the absence of any scientific study about the side effects of Lignocad Adr in breastfeeding women, information on safety of Lignocad Adr is unavailable.
What is the effect of Lignocad Adr on the Kidneys?
In the absence of any research, there are no known side effects of Lignocad Adr on kidneys.
What is the effect of Lignocad Adr on the Liver?
So far, no research has been carried out on the effects of Lignocad Adr on the liver. So it is not known whether taking Lignocad Adr will affect the liver or not.
What is the effect of Lignocad Adr on the Heart?
Information about safety of Lignocad Adr for heart is not available since scientific research on this is yet to be done.
Lignocad Adr should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lignocad Adr unless your doctor advises you to do so -
Is this Lignocad Adr habit forming or addictive?
Lignocad Adr does not cause addiction.
Interaction between Food and Lignocad Adr
There is no information on the effects of taking Lignocad Adr with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Lignocad Adr
Information about the interaction of Lignocad Adr and alcohol is not currently available because this topic has not been researched yet.
According to an FDA warning published in 2014, a 2% solution of Lignocad Adr should not be used in infants and young children (5 months to 3.5 years old), as too much application of Lignocad Adr or accidental swallowing may cause serious brain injury, seizures, and heart problems. Therefore, for treating teething pain, one must take the advice of their doctor and follow his recommendations completely.
Yes, Lignocad Adr is used topically for producing an anesthetic effect (Prevent pain) on the irritated or inflamed mucous membranes of mouth and pharynx. It is also used for minimizing gagging during X-ray procedure and dental impressions.
Yes, Lignocad Adr is used in combination with prilocaine for premature ejaculation. It improves sexual satisfaction and ejaculatory control by decreasing the sensation of the genital skin. It has no systemic effects and has minimum local side effects. Premature ejaculation can be psychological or biological. It could be because of over-sensitive genital skin, extreme arousal, infrequent sexual activity, hyperactive reflexes, fear, performance anxiety, use of alcohol and other substances, inflammation of the urethra, prostate, etc. In addition, it is also important to take treatment and comply with it completely.
Yes, Lignocad Adr may cause an allergic reaction which might manifest as sneezing, wheezing, pruritis (severe itching of the skin), urticaria (localized swollen itchy area), episodes of angioneurotic edema (swelling of the lower layer of skin or mucous membranes and even anaphylactic shock (very severe allergic reaction). If you develop any of these symptoms while using Lignocad Adr, please inform your doctor immediately.
Lignocad Adr is a brand name for lidocaine. It is a prescription drug that belongs to the class of medications called local anesthetic agent. Lignocad Adr is available in different dosage forms such as injection, gel, spray, patch, and solution. It is mainly used to reduce pain and discomfort caused by skin irritation and sunburn. Some form of Lignocad Adr is used to reduce pain and discomfort arises before certain surgery (small) and medical examination or procedure. The injectable form of Lignocad Adr is mainly used for the treatment of ventricular arrhythmias (irregular heartbeat).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Adrenalin (epinephrine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 133
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Adrenaline (epinephrine)*
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sodium Chloride